Efficacy of Gut-Brain Neuromodulators in the Treatment of Gastroesophageal Reflux Disease

NAActive, not recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

April 24, 2025

Primary Completion Date

July 1, 2025

Study Completion Date

September 30, 2025

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG

Flupentixol-Melitracen + Lansoprazole

Flupentixol-Melitracen and Lansoprazole for the treatment of GERD

DRUG

Lansoprazole and placebo

Placebo and Lansoprazole for GERD

Trial Locations (1)

Shanghai Jiaotong university，renji hospital, Shanghai

All Listed Sponsors

lead

RenJi Hospital

OTHER

NCT06945237 - Efficacy of Gut-Brain Neuromodulators in the Treatment of Gastroesophageal Reflux Disease | Biotech Hunter | Biotech Hunter